Related by context. Frequent words. (Click for all words.) 69 Completes Enrollment 69 Presents Positive 69 FDA Accepts 67 submitted Biologics License 67 Application BLA 66 Crucell NV Euronext 66 Receives FDA Clearance 66 NASDAQ CRXL 65 Application MAA 65 Initiates Phase 65 Phase III Clinical Trial 64 Inc. Nasdaq IMGN 64 Generic Version 64 Drug Candidate 63 Company Nasdaq PRGO 63 FDA Clears 63 Pivotal Phase III 63 submitted Marketing Authorization 63 Announces Initiation 62 refractory chronic lymphocytic 62 Pivotal Trial 62 Patient Enrollment 62 supplemental Biologics License Application 61 Nasdaq VRTX 61 Act PDUFA date 61 Regains Compliance 61 Phase III Trial 61 FDA Approves 61 Recombinant Human 61 Biologics License Application 60 Clinical Trial Results 60 NASDAQ SHPGY 60 Patent Covering 60 R sorafenib tablets 60 Preclinical Data 60 Initiate Phase 60 Announces Positive 60 EPIX Pharmaceuticals 60 Monoclonal Antibody 60 Hold Fourth Quarter 59 EPIX Pharmaceuticals Inc. 59 Palatin Technologies Inc. 59 Q2 Loss Narrows 59 Q2 Loss Widens 59 application sNDA 59 HAYWARD Calif. BUSINESS WIRE 59 humanized anti 59 FDA Orphan Drug 59 Stockholders Approve Merger 59 FDA Clearance 59 Receives Patent 59 Regains Compliance With 59 Announces Stockholder Approval 59 FDA Approval 58 Complete Merger 58 Protalix BioTherapeutics Inc. 58 Ixempra 58 Idera Pharmaceuticals 58 Panzem R 58 RNAi Therapeutics 58 sodium phosphate dibasic anhydrous 58 ZALBIN 58 Well Tolerated 58 Small Molecule 58 Surgical Adhesive 58 ACADIA Pharmaceuticals 58 Commence Trading 58 Response Biomedical Corporation 58 Completes Tender Offer 58 Protalix BioTherapeutics 58 Extends Tender Offer 58 Files Annual Report 58 Orphan Drug status 58 Patent Issued 58 Combination Therapy 58 Reports Positive 58 Pivotal Phase 58 Inc. NASDAQ MRNA 57 OTCQX RHHBY 57 Commercialize 57 Issues Guidance 57 Drug Applications ANDAs 57 CoTherix Inc. 57 VIA Pharmaceuticals 57 Metabasis Therapeutics Inc. 57 Low Dose 57 Updates Guidance 57 Andrx Corporation 57 Provides Guidance 57 Drug Resistant 57 BPAX 57 Orphan Drug designation 57 Positive Opinion 57 Investigational Device Exemption 56 FDA Warns 56 Extended Release 56 Webcast Annual Meeting 56 Drug Application 56 Cholesterol Drug 56 Oral Solution 56 Receives Notice